241 related articles for article (PubMed ID: 16649559)
1. Pluronic F127 gel effectively controls the burst release of drug from PLGA microspheres.
Wang Y; Gao JQ; Chen HL; Zheng CH; Liang WQ
Pharmazie; 2006 Apr; 61(4):367-8. PubMed ID: 16649559
[TBL] [Abstract][Full Text] [Related]
2. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
3. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
4. Elevated temperature accelerated release testing of PLGA microspheres.
Zolnik BS; Leary PE; Burgess DJ
J Control Release; 2006 May; 112(3):293-300. PubMed ID: 16644055
[TBL] [Abstract][Full Text] [Related]
5. Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms.
Santander-Ortega MJ; Jódar-Reyes AB; Csaba N; Bastos-González D; Ortega-Vinuesa JL
J Colloid Interface Sci; 2006 Oct; 302(2):522-9. PubMed ID: 16887138
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
Kim HK; Chung HJ; Park TG
J Control Release; 2006 May; 112(2):167-74. PubMed ID: 16542746
[TBL] [Abstract][Full Text] [Related]
7. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of recombinant human growth hormone against emulsification-induced aggregation by Pluronic surfactants during microencapsulation.
Wei G; Lu LF; Lu WY
Int J Pharm; 2007 Jun; 338(1-2):125-32. PubMed ID: 17336005
[TBL] [Abstract][Full Text] [Related]
10. Controlled delivery of aspirin: effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems.
Tang Y; Singh J
Int J Pharm; 2008 Jun; 357(1-2):119-25. PubMed ID: 18329202
[TBL] [Abstract][Full Text] [Related]
11. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
12. Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique.
Paillard-Giteau A; Tran VT; Thomas O; Garric X; Coudane J; Marchal S; Chourpa I; Benoît JP; Montero-Menei CN; Venier-Julienne MC
Eur J Pharm Biopharm; 2010 Jun; 75(2):128-36. PubMed ID: 20226857
[TBL] [Abstract][Full Text] [Related]
13. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
[TBL] [Abstract][Full Text] [Related]
14. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres.
Xu Q; Czernuszka JT
J Control Release; 2008 Apr; 127(2):146-53. PubMed ID: 18325617
[TBL] [Abstract][Full Text] [Related]
16. A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres.
Zheng CH; Gao JQ; Zhang YP; Liang WQ
Biochem Biophys Res Commun; 2004 Oct; 323(4):1321-7. PubMed ID: 15451441
[TBL] [Abstract][Full Text] [Related]
17. A one-step modified method to reduce the burst initial release from PLGA microspheres.
Zheng C; Liang W
Drug Deliv; 2010 Feb; 17(2):77-82. PubMed ID: 20067365
[TBL] [Abstract][Full Text] [Related]
18. Lactic acid triggers, in vitro, thiomersal to degrade protein in the presence of PLGA microspheres.
Namur JA; Takata CS; Moro AM; Politi MJ; De Araujo PS; Cuccovia IM; Da Costa MH
Int J Pharm; 2004 Apr; 273(1-2):1-8. PubMed ID: 15010124
[TBL] [Abstract][Full Text] [Related]
19. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
Díez S; Tros de Ilarduya C
Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
[TBL] [Abstract][Full Text] [Related]
20. Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique.
Ito F; Fujimori H; Honnami H; Kawakami H; Kanamura K; Makino K
Colloids Surf B Biointerfaces; 2008 Oct; 66(1):65-70. PubMed ID: 18585903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
